Autolus Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
LONDON, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that Dr. Christian Itin, chairman and chief executive …